SONVF:OTO-Sonova Holding AG (USD)

COMMON STOCK | Medical Devices | OTC Pink

Last Closing

USD 318.972

Change

0.00 (0.00)%

Market Cap

USD 8.64B

Volume

99.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Sonova Holding AG along with its subsidiaries is engaged in the design, development, manufacture, distribution and service of technologically advanced hearing systems for adults and children with hearing impairment.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

N/A

USD 65.44B
SMMNY Siemens Healthineers AG ADR

+0.12 (+0.42%)

USD 63.58B
RYLPF Koninklijke Philips N.V

-0.08 (-0.31%)

USD 25.83B
SONVY Sonova Holding AG

-0.24 (-0.39%)

USD 18.55B
CHEOY CochLear Ltd ADR

+1.66 (+1.53%)

USD 14.32B
CHEOF Cochlear Limited

+5.46 (+2.58%)

USD 13.46B
SNNUF Smith & Nephew plc

N/A

USD 10.97B
WILLF Demant A/S

-2.74 (-5.79%)

USD 10.12B
WILYY Demant A/S ADR

N/A

USD 10.08B
AMBFF Ambu A/S

N/A

USD 5.40B

ETFs Containing SONVF

EMID:LSE iShares MSCI Europe Mid C.. 0.00 % 0.00 %

-0.05 (-0.69%)

USD 0.01B
EUMD:LSE iShares MSCI Europe Mid C.. 0.00 % 0.00 %

-0.05 (-0.69%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.99% 60% D- 51% F
Dividend Return 1.47% 40% F 30% F
Total Return 0.48% 60% D- 50% F
Trailing 12 Months  
Capital Gain 20.46% 73% C 76% C+
Dividend Return 1.79% 67% D+ 23% F
Total Return 22.25% 73% C 75% C
Trailing 5 Years  
Capital Gain 36.21% 76% C+ 77% C+
Dividend Return 7.69% 67% D+ 25% F
Total Return 43.89% 77% C+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 11.73% 64% D 74% C
Dividend Return 12.85% 70% C- 72% C
Total Return 1.12% 50% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 33.89% 55% F 30% F
Risk Adjusted Return 37.93% 70% C- 60% D-
Market Capitalization 8.64B 98% N/A 94% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.